However, in post-mortem human brains expression of the efflux transporter MATE1 was lower in individuals with AD compared to age-matched healthy controls in the putamen; and PMAT showed a similar trend in the caudate nucleus, but there was no change in expression levels of these transporters in the frontal cortex. This evidence concerns the gene SLC29A4 and Alzheimer disease.